C4 Therapeutics (CCCC)
US Market

C4 Therapeutics Balance Sheet


C4 Therapeutics Balance Sheet

C4 Therapeutics's total assets for Q2 2022 were $492.48M, a decrease of -4.46% from the previous quarter. CCCC total liabilities were $147.88M for the fiscal quarter, a -2.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 506.76M$ 400.14M$ 118.26M$ 146.49M
Total Liabilities
$ 117.16M$ 119.35M$ 230.22M$ 226.24M
Total Equity Gross Minority
$ 389.61M$ 280.79M$ -111.96M$ -79.75M
Total Capitalization
$ 400.37M$ 290.84M$ -111.96M$ -79.75M
Preferred Stock Equity
--$ 111.00M$ 111.00M
Capital Lease Obligations
$ 32.11M$ 12.87M$ 13.75M$ 14.48M
Currency in USD

C4 Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis